Serina Therapeutics (FRA:2BO) Other Operating Expense : €-0.05 Mil (TTM As of Mar. 2025)

View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Other Operating Expense?

Serina Therapeutics's Other Operating Expense for the three months ended in Mar. 2025 was €-0.00 Mil. Its Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was €-0.05 Mil.

Serina Therapeutics's quarterly Other Operating Expense increased from Sep. 2024 (€-0.01 Mil) to Dec. 2024 (€0.01 Mil) but then declined from Dec. 2024 (€0.01 Mil) to Mar. 2025 (€-0.00 Mil).

Serina Therapeutics's annual Other Operating Expense declined from Dec. 2022 (€-0.09 Mil) to Dec. 2023 (€-0.14 Mil) but then increased from Dec. 2023 (€-0.14 Mil) to Dec. 2024 (€-0.05 Mil).

Serina Therapeutics Other Operating Expense Historical Data

The historical data trend for Serina Therapeutics's Other Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Other Operating Expense Chart

Serina Therapeutics Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Other Operating Expense

-0.38

-0.09

-0.14

-0.05

Serina Therapeutics Quarterly Data
	Dec21	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
Other Operating Expense	Get a 7-Day Free Trial						-0.01	-0.05	-0.01	0.01	-

Serina Therapeutics Other Operating Expense Calculation

GuruFocus uses a standardized financial statement format for all companies. For non-financial companies, GuruFocus lists Selling, General, & Admin. Expense, , Research & Development, and Other Operating Expense under the "Total Operating Expense" section.

Other Operating Expense sometimes includes:
Restructuring, and merger
Acquisition related and other
Litigation settlement charge
Other (too numerous to list)

Some companies can and do choose to report each of these items separately. Yet, there are a variety of Other Operating Expense which are simply too numerous to list.

Other Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.05 Mil.

Serina Therapeutics Other Operating Expense Related Terms

Thank you for viewing the detailed overview of Serina Therapeutics's Other Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Serina Therapeutics Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (FRA:2BO) » Definitions » Other Operating Expense

Comparable Companies

Traded in Other Exchanges

SER:USA

Address

601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806

Website

https://www.serinatherapeutics.com

Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers. The Company has one reportable segment relating to the research and development of its POZ platform.

Serina Therapeutics Headlines

No Headlines